Rafael Bejar - Net Worth and Insider Trading

Rafael Bejar Net Worth

The estimated net worth of Rafael Bejar is at least $767 dollars as of 2024-05-21. Rafael Bejar is the Sr. VP, Chief Medical Officer of Aptose Biosciences Inc and owns about 667 shares of Aptose Biosciences Inc (APTO) stock worth over $767. Details can be seen in Rafael Bejar's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Rafael Bejar has not made any transactions after 2021-11-19 and currently still holds the listed stock(s).

Transaction Summary of Rafael Bejar

To

Rafael Bejar Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Rafael Bejar owns 1 companies in total, including Aptose Biosciences Inc (APTO) .

Click here to see the complete history of Rafael Bejar’s form 4 insider trades.

Insider Ownership Summary of Rafael Bejar

Ticker Comapny Transaction Date Type of Owner
APTO Aptose Biosciences Inc 2021-11-19 Chief Medical Officer

Rafael Bejar Latest Holdings Summary

Rafael Bejar currently owns a total of 1 stock. Rafael Bejar owns 667 shares of Aptose Biosciences Inc (APTO) as of November 19, 2021, with a value of $767.

Latest Holdings of Rafael Bejar

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
APTO Aptose Biosciences Inc 2021-11-19 667 1.15 767

Holding Weightings of Rafael Bejar


Rafael Bejar Form 4 Trading Tracker

According to the SEC Form 4 filings, Rafael Bejar has made a total of 1 transactions in Aptose Biosciences Inc (APTO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Aptose Biosciences Inc is the acquisition of 667 shares on November 19, 2021, which cost Rafael Bejar around $25,600.

Insider Trading History of Rafael Bejar

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Rafael Bejar Trading Performance

GuruFocus tracks the stock performance after each of Rafael Bejar's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rafael Bejar is -53.39%. GuruFocus also compares Rafael Bejar's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rafael Bejar within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Rafael Bejar's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Rafael Bejar

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -40.24
Relative Return to S&P 500(%) -38.59

Rafael Bejar Ownership Network

Ownership Network List of Rafael Bejar

No Data

Ownership Network Relation of Rafael Bejar


Rafael Bejar Owned Company Details

What does Aptose Biosciences Inc do?

Who are the key executives at Aptose Biosciences Inc?

Rafael Bejar is the Chief Medical Officer of Aptose Biosciences Inc. Other key executives at Aptose Biosciences Inc include director & Chair & President & CEO William G. Rice , SR VP & Chief Fin. Officer Fletcher Payne , and Chief Commercial Officer Philippe Ledru .

Aptose Biosciences Inc (APTO) Insider Trades Summary

Over the past 18 months, Rafael Bejar made no insider transaction in Aptose Biosciences Inc (APTO). Other recent insider transactions involving Aptose Biosciences Inc (APTO) include a net purchase of 17,000 shares made by Bernd R. Seizinger ,

In summary, during the past 3 months, insiders sold 0 shares of Aptose Biosciences Inc (APTO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Aptose Biosciences Inc (APTO) were sold and 17,000 shares were bought by its insiders, resulting in a net purchase of 17,000 shares.

Aptose Biosciences Inc (APTO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Aptose Biosciences Inc Insider Transactions

No Available Data

Rafael Bejar Mailing Address

Above is the net worth, insider trading, and ownership report for Rafael Bejar. You might contact Rafael Bejar via mailing address: C/o Aptose Biosciences Inc., 251 Consumers Road, Suite 1105, Toronto A6 M2j 4r3.

Discussions on Rafael Bejar

No discussions yet.